S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

CVE:MFSMedifocus Stock Price, Forecast & News

C$0.0050
-327,141.00 (-100.00 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
C$0.01
Now: C$0.01
C$0.01
50-Day Range
C$0.01
MA: C$0.01
C$0.01
52-Week Range
C$0.01
Now: C$0.01
C$0.03
Volume25,000 shs
Average Volume104,118 shs
Market CapitalizationC$924,920.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medifocus Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus Inc. has a patent license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy for the treatment of cancers and other diseases. The company is based in Columbia, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-3197070

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$2.23 million
Cash FlowC$0.00 per share
Book ValueC($0.07) per share

Profitability

Miscellaneous

Employees7
Market CapC$924,920.00
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive MFS News and Ratings via Email

Sign-up to receive the latest news and ratings for MFS and its competitors with MarketBeat's FREE daily newsletter.


Medifocus (CVE:MFS) Frequently Asked Questions

When is Medifocus' next earnings date?

Medifocus is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Medifocus.

Has Medifocus been receiving favorable news coverage?

Media stories about MFS stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medifocus earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutMedifocus.

Who are some of Medifocus' key competitors?

What other stocks do shareholders of Medifocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifocus investors own include Relypsa (RLYP), Chevron (CVX), BP Prudhoe Bay Royalty Trust (BPT), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE) and Axon Enterprise (AAXN).

Who are Medifocus' key executives?

Medifocus' management team includes the following people:
  • Dr. William W. Jow, CEO, Pres & Director (Age 61)
  • Mr. Mirsad Jakubovic C.A., M.B.A., Chief Financial Officer (Age 57)
  • Mr. John Mon, VP of Regulatory Affairs & Product Devel. (Age 66)
  • Mr. Douglas Liu, VP of Fin. (Age 55)
  • Dr. Stuart E. Katz M.D., VP of Operations

What is Medifocus' stock symbol?

Medifocus trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MFS."

How do I buy shares of Medifocus?

Shares of MFS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Medifocus' stock price today?

One share of MFS stock can currently be purchased for approximately C$0.01.

How big of a company is Medifocus?

Medifocus has a market capitalization of C$924,920.00 and generates C$2.23 million in revenue each year. Medifocus employs 7 workers across the globe. View additional information about Medifocus.

What is Medifocus' official website?

The official website for Medifocus is http://www.medifocusinc.com/.

How can I contact Medifocus?

Medifocus' mailing address is The Exchange Tower Suite 1800, 130 King Street West, PO Box 427, TORONTO, ON M5X 1E3, Canada. The company can be reached via phone at +1-905-3197070.

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel